Research Archives - Cyclotek

Cyclotek lends a hand in PSMA-PET in Active Surveillance for Ca Prostate

Posted on: 09 June 2022Research

Cyclotek is collaborating with Whitten Foundation-led research to pave the way for better det
read More
Cyclotek supports Macquarie University’s Research Studies in Motor Neuron Disease (MND)

Posted on: 16 February 2022Research

In collaboration with Macquarie University and Life Molecular Imaging (LMI), Cyclotek is plea
read More
Neuroinflammation as a Mechanism, Biomarker, and Therapeutic Target in Degenerative Brain Disorders

Posted on: 15 October 2017Research

Immune-responsive cells of the brain – namely microglia and astrocytes – activate in resp
read More
ASAN Medical Centre and Duchembio, Korea, licence DAT PET tracer for Parkinson’s to Cyclotek

Posted on: 05 July 2017Research

ASAN Medical Center and Duchembio Co. Ltd. announce Strategic Partnership with Cyclotek for E
read More
Prostate tracers [18F]DCFPyL and [68Ga]PSMA comparison

Posted on: 10 July 2016Latest News,Research

Paper compares [68Ga] and [18F] PSMA labeled tracers
read More
Cyclotek supports pilot PET clinical trial in multiple sclerosis (MS)

Posted on: 10 March 2016Research

F18-FEMPA is a novel radiotracer owned by Piramal Imaging and produced under license by Cyclo
read More

© 2024 Cyclotek. All rights reserved

[contact-form-7 id=”714″ title=”Update Form”]